Medios AG Company Description

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany.

It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.

The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies.

This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.

Medios AG was founded in 2016 and is headquartered in Berlin, Germany.

Medios AG

Country	Germany
Founded	2016
Industry	Medical Distribution
Sector	Healthcare
Employees	515
CEO	Matthias Gaertner

Contact Details

Address: Heidestrasse 9 Berlin, 10557 Germany
Phone	49 30 232 5668 00
Website	medios.ag

Stock Details

Ticker Symbol	ILM1
Exchange	Deutsche Börse Xetra
Fiscal Year	January - December
Reporting Currency	EUR
ISIN Number	DE000A1MMCC8
SIC Code	5122

Key Executives

Name	Position
Matthias Gaertner	Chief Executive Officer and Chairman of the Executive Board
Dr. Yann Samson	Chairman of Supervisory Board and Sustainability Officer
Falk Neukirch	Chief Financial Officer and Member of Executive Board
Christoph Prußeit	Chief Innovation Officer and Member of Executive Board
Mi-Young Miehler	Chief Operating Officer and Member of Executive Board
Constantijn van Rietschoten	Chief of International Markets and Member of Executive Board
Claudia Nickolaus	Head of Investor and Public Relations